STAT3 activation impairs the stability of Th9 cells

Journal of Immunology

Volumn 198, Issue 6, 2017, Pages 2302-2309

  Ulrich, Benjamin J ^a   Verdan, Felipe Fortino ^b   McKenzie, Andrew N J ^c   Kaplan, Mark H ^a   Olson, Matthew R ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c MRC LABORATORY OF MOLECULAR BIOLOGY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 9; STAT3 PROTEIN; STAT3 PROTEIN, MOUSE;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL LEVEL; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; GROWTH RATE; IN VITRO STUDY; MOLECULAR DYNAMICS; MOUSE; NONHUMAN; PHENOTYPE; TH9 CELL; ANIMAL; C57BL MOUSE; CD4+ T LYMPHOCYTE; CELL CULTURE; CELL SURVIVAL; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; INFLAMMATION; KNOCKOUT MOUSE; METABOLISM; PHOSPHORYLATION; SIGNAL TRANSDUCTION;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CELL DIFFERENTIATION; CELL SURVIVAL; CELLS, CULTURED; GENE EXPRESSION REGULATION; INFLAMMATION; INTERLEUKIN-10; INTERLEUKIN-9; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PHOSPHORYLATION; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR;

EID: 85014683588     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1601624     Document Type: Article

References (36)

1. Zhu, J., H. Yamane, and W. E. Paul. 2010. Differentiation of effector CD4 T cell populations. Annu. Rev. Immunol. 28: 445-489.
2. Hegazy, A. N., M. Peine, C. Helmstetter, I. Panse, A. Fröhlich, A. Bergthaler, L. Flatz, D. D. Pinschewer, A. Radbruch, and M. Löhning. 2010. Interferons direct Th2 cell reprogramming to generate a stable GATA-3+T-bet+ cell subset with combined Th2 and Th1 cell functions. Immunity 32: 116-128.
3. Lee, Y. K., H. Turner, C. L. Maynard, J. R. Oliver, D. Chen, C. O. Elson, and C. T. Weaver. 2009. Late developmental plasticity in the T helper 17 lineage. Immunity 30: 92-107.
4. Mathur, A. N., H. C. Chang, D. G. Zisoulis, R. Kapur, M. L. Belladonna, G. S. Kansas, and M. H. Kaplan. 2006. T-bet is a critical determinant in the instability of the IL-17-secreting T-helper phenotype. Blood 108: 1595-1601.
5. Mukasa, R., A. Balasubramani, Y. K. Lee, S. K. Whitley, B. T. Weaver, Y. Shibata, G. E. Crawford, R. D. Hatton, and C. T. Weaver. 2010. Epigenetic instability of cytokine and transcription factor gene loci underlies plasticity of the T helper 17 cell lineage. Immunity 32: 616-627.
6. Stritesky, G. L., N. Yeh, and M. H. Kaplan. 2008. IL-23 promotes maintenance but not commitment to the Th17 lineage. J. Immunol. 181: 5948-5955.
7. Hirota, K., J. H. Duarte, M. Veldhoen, E. Hornsby, Y. Li, D. J. Cua, H. Ahlfors, C. Wilhelm, M. Tolaini, U. Menzel, et al. 2011. Fate mapping of IL-17-producing T cells in inflammatory responses. Nat. Immunol. 12: 255-263.
8. Wei, G., L. Wei, J. Zhu, C. Zang, J. Hu-Li, Z. Yao, K. Cui, Y. Kanno, T. Y. Roh, W. T. Watford, et al. 2009. Global mapping of H3K4me3 and H3K27me3 reveals specificity and plasticity in lineage fate determination of differentiating CD4+ T cells. Immunity 30: 155-167.
9. Kaplan, M. H., M. M. Hufford, and M. R. Olson. 2015. The development and in vivo function of T helper 9 cells. Nat. Rev. Immunol. 15: 295-307.
10. Koh, B., M. M. Hufford, D. Pham, M. R. Olson, T. Wu, R. Jabeen, X. Sun, and M. H. Kaplan. 2016. The ETS family transcription factors Etv5 and PU.1 function in parallel to promote Th9 cell development. J. Immunol. 197: 2465-2472.
11. Jäger, A., V. Dardalhon, R. A. Sobel, E. Bettelli, and V. K. Kuchroo. 2009. Th1, Th17, and Th9 effector cells induce experimental autoimmune encephalomyelitis with different pathological phenotypes. J. Immunol. 183: 7169-7177.
12. Tan, C., M. K. Aziz, J. D. Lovaas, B. P. Vistica, G. Shi, E. F. Wawrousek, and I. Gery. 2010. Antigen-specific Th9 cells exhibit uniqueness in their kinetics of cytokine production and short retention at the inflammatory site. J. Immunol. 185: 6795-6801.
13. Licona-Limón, P., J. Henao-Mejia, A. U. Temann, N. Gagliani, I. Licona-Limón, H. Ishigame, L. Hao, D. R. Herbert, and R. A. Flavell. 2013. Th9 cells drive host immunity against gastrointestinal worm infection. Immunity 39: 744-757.
14. Sehra, S., W. Yao, E. T. Nguyen, N. L. Glosson-Byers, N. Akhtar, B. Zhou, and M. H. Kaplan. 2015. TH9 cells are required for tissue mast cell accumulation during allergic inflammation. J. Allergy Clin. Immunol. 136: 433-440.e1.
15. Staudt, V., E. Bothur, M. Klein, K. Lingnau, S. Reuter, N. Grebe, B. Gerlitzki, M. Hoffmann, A. Ulges, C. Taube, et al. 2010. Interferon-regulatory factor 4 is essential for the developmental program of T helper 9 cells. Immunity 33: 192-202.
16. Yao, W., Y. Zhang, R. Jabeen, E. T. Nguyen, D. S. Wilkes, R. S. Tepper, M. H. Kaplan, and B. Zhou. 2013. Interleukin-9 is required for allergic airway inflammation mediated by the cytokine TSLP. Immunity 38: 360-372.
17. Brough, H. A., D. J. Cousins, A. Munteanu, Y. F. Wong, A. Sudra, K. Makinson, A. C. Stephens, M. Arno, L. Ciortuz, G. Lack, and V. Turcanu. 2014. IL-9 is a key component of memory TH cell peanut-specific responses from children with peanut allergy. J. Allergy Clin. Immunol. 134: 1329-1338.e10.
18. Xie, J., L. C. Lotoski, R. Chooniedass, R. C. Su, F. E. Simons, J. Liem, A. B. Becker, J. Uzonna, and K. T. HayGlass. 2012. Elevated antigen-driven IL-9 responses are prominent in peanut allergic humans. PLoS One 7: e45377.
19. Yao, W., R. S. Tepper, and M. H. Kaplan. 2011. Predisposition to the development of IL-9-secreting T cells in atopic infants. J. Allergy Clin. Immunol. 128: 1357-1360.e5.
20. Agarwal, S., and A. Rao. 1998. Modulation of chromatin structure regulates cytokine gene expression during T cell differentiation. Immunity 9: 765-775.
21. Bird, J. J., D. R. Brown, A. C. Mullen, N. H. Moskowitz, M. A. Mahowald, J. R. Sider, T. F. Gajewski, C. R. Wang, and S. L. Reiner. 1998. Helper T cell differentiation is controlled by the cell cycle. Immunity 9: 229-237.
22. Murphy, E., K. Shibuya, N. Hosken, P. Openshaw, V. Maino, K. Davis, K. Murphy, and A. O'Garra. 1996. Reversibility of T helper 1 and 2 populations is lost after long-term stimulation. J. Exp. Med. 183: 901-913.
23. Gerlach, K., Y. Hwang, A. Nikolaev, R. Atreya, H. Dornhoff, S. Steiner, H. A. Lehr, S. Wirtz, M. Vieth, A. Waisman, et al. 2014. TH9 cells that express the transcription factor PU.1 drive T cell-mediated colitis via IL-9 receptor signaling in intestinal epithelial cells. Nat. Immunol. 15: 676-686.
24. Chiarle, R.,W. J. Simmons, H. Cai, G. Dhall, A. Zamo, R. Raz, J. G. Karras, D. E. Levy, and G. Inghirami. 2005. Stat3 is required for ALK-mediated lymphomagenesis and provides a possible therapeutic target. Nat. Med. 11: 623-629.
25. Olson, M. R., F. F. Verdan, M. M. Hufford, A. L. Dent, and M. H. Kaplan. 2016. STAT3 impairs STAT5 activation in the development of IL-9-secreting T cells. J. Immunol. 196: 3297-3304.
26. Chang, H. C., S. Sehra, R. Goswami, W. Yao, Q. Yu, G. L. Stritesky, R. Jabeen, C. McKinley, A. N. Ahyi, L. Han, et al. 2010. The transcription factor PU.1 is required for the development of IL-9-producing T cells and allergic inflammation. Nat. Immunol. 11: 527-534.
27. Hedrich, C. M., and J. H. Bream. 2010. Cell type-specific regulation of IL-10 expression in inflammation and disease. Immunol. Res. 47: 185-206.
28. Schmitt, E., T. Germann, S. Goedert, P. Hoehn, C. Huels, S. Koelsch, R. Kuhn, W. Muller, N. Palm, and E. Rude. 1994. IL-9 production of naive CD4+ T cells depends on IL-2, is synergistically enhanced by a combination of TGF-beta and IL-4, and is inhibited by IFN-gamma. J. Immunol. 153: 3989-3996.
29. Ives, M. L., C. S. Ma, U. Palendira, A. Chan, J. Bustamante, S. Boisson-Dupuis, P. D. Arkwright, D. Engelhard, D. Averbuch, K. Magdorf, et al. 2013. Signal transducer and activator of transcription 3 (STAT3) mutations underlying autosomal dominant hyper-IgE syndrome impair human CD8+ T-cell memory formation and function. J. Allergy Clin. Immunol. 132: 400-411.e9.
30. Wehinger, J., F. Gouilleux, B. Groner, J. Finke, R. Mertelsmann, and R. M. Weber-Nordt. 1996. IL-10 induces DNA binding activity of three STAT proteins (Stat1, Stat3, and Stat5) and their distinct combinatorial assembly in the promoters of selected genes. FEBS Lett. 394: 365-370.
31. Lu, Y., S. Hong, H. Li, J. Park, B. Hong, L. Wang, Y. Zheng, Z. Liu, J. Xu, J. He, et al. 2012. Th9 cells promote antitumor immune responses in vivo. J. Clin. Invest. 122: 4160-4171.
32. Végran, F., H. Berger, R. Boidot, G. Mignot, M. Bruchard, M. Dosset, F. Chalmin, C. Rébé, V. Dérangère, B. Ryffel, et al. 2014. The transcription factor IRF1 dictates the IL-21-dependent anticancer functions of TH9 cells. Nat. Immunol. 15: 758-766.
33. Lexberg, M. H., A. Taubner, A. Fö rster, I. Albrecht, A. Richter, T. Kamradt, A. Radbruch, and H. D. Chang. 2008. Th memory for interleukin-17 expression is stable in vivo. Eur. J. Immunol. 38: 2654-2664.
34. Wong, M. T., J. J. Ye, M. N. Alonso, A. Landrigan, R. K. Cheung, E. Engleman, and P. J. Utz. 2010. Regulation of human Th9 differentiation by type I interferons and IL-21. Immunol. Cell Biol. 88: 624-631.
35. Glosson-Byers, N. L., S. Sehra, G. L. Stritesky, Q. Yu, O. Awe, D. Pham, H. A. Bruns, and M. H. Kaplan. 2014. Th17 cells demonstrate stable cytokine production in a proallergic environment. J. Immunol. 193: 2631-2640.
36. Croxford, A. L., F. C. Kurschus, and A. Waisman. 2009. Cutting edge: an IL-17F-CreEYFP reporter mouse allows fate mapping of Th17 cells. J. Immunol. 182: 1237-1241.